Relationship between crystallization tendencies during cooling from melt and isothermal storage: toward a general understanding of physical stability of pharmaceutical glasses
- PMID: 24731254
- DOI: 10.1021/mp400679m
Relationship between crystallization tendencies during cooling from melt and isothermal storage: toward a general understanding of physical stability of pharmaceutical glasses
Abstract
The lack of protocols to predict the physical stability has been one of the most important issues in the use of amorphous solid dispersions. In this paper, the crystallization behaviors of pharmaceutical glasses, which have large variations in their crystallization tendencies, have been investigated. Although each compound appears to have a wide variation in their crystallization time, the initiation time for crystallization could be generalized as a function of only Tg/T, where Tg and T are the glass transition temperature and storage temperature, respectively. All compounds in which crystallization was mainly governed by temperature had similar activation energies for crystallization initiation, ca. 210-250 kJ/mol, indicating that physical stability at any temperature is predictable from only Tg. Increased stability is expected for other compounds, where crystallization is inhibited by an large energetic barrier, and stochastic nucleation plays an important role in initiating crystallization. The difference in the dominant factor, either temperature or pressure, appeared to correlate with the nucleation mechanism, and this could be determined by a cool-heat cycle after melting using thermal analysis. This conclusion should make prediction of physical stability of amorphous formulations easier, although the investigation was conducted under ideal conditions, which eliminated surface effects.
Similar articles
-
Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions.Pharmaceutics. 2019 May 1;11(5):202. doi: 10.3390/pharmaceutics11050202. Pharmaceutics. 2019. PMID: 31052392 Free PMC article. Review.
-
Physical Stabilization of Pharmaceutical Glasses Based on Hydrogen Bond Reorganization under Sub-Tg Temperature.Mol Pharm. 2017 Jan 3;14(1):264-273. doi: 10.1021/acs.molpharmaceut.6b00866. Epub 2016 Dec 2. Mol Pharm. 2017. PMID: 28043129
-
Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.J Pharm Sci. 2012 Sep;101(9):3239-48. doi: 10.1002/jps.23166. Epub 2012 Apr 24. J Pharm Sci. 2012. PMID: 22531946
-
Early drug development predictions of glass-forming ability and physical stability of drugs.Eur J Pharm Sci. 2013 May 13;49(2):323-32. doi: 10.1016/j.ejps.2013.03.016. Epub 2013 Apr 2. Eur J Pharm Sci. 2013. PMID: 23557841
-
Supersaturation and crystallization: non-equilibrium dynamics of amorphous solid dispersions for oral drug delivery.Expert Opin Drug Deliv. 2017 Jun;14(6):735-743. doi: 10.1080/17425247.2017.1230099. Epub 2016 Sep 9. Expert Opin Drug Deliv. 2017. PMID: 27598556 Review.
Cited by
-
Physicochemical Properties of Solid Phospholipid Particles as a Drug Delivery Platform for Improving Oral Absorption of Poorly Soluble Drugs.Pharm Res. 2017 Jan;34(1):208-216. doi: 10.1007/s11095-016-2056-4. Epub 2016 Nov 7. Pharm Res. 2017. PMID: 27822849
-
Formation of a Stable Co-Amorphous System for a Brick Dust Molecule by Utilizing Sodium Taurocholate with High Glass Transition Temperature.Pharmaceutics. 2022 Dec 27;15(1):84. doi: 10.3390/pharmaceutics15010084. Pharmaceutics. 2022. PMID: 36678713 Free PMC article.
-
Ternary Eutectic Ezetimibe-Simvastatin-Fenofibrate System and the Physical Stability of Its Amorphous Form.Mol Pharm. 2021 Sep 6;18(9):3588-3600. doi: 10.1021/acs.molpharmaceut.1c00485. Epub 2021 Aug 22. Mol Pharm. 2021. PMID: 34420300 Free PMC article.
-
Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions.Pharmaceutics. 2019 May 1;11(5):202. doi: 10.3390/pharmaceutics11050202. Pharmaceutics. 2019. PMID: 31052392 Free PMC article. Review.
-
Glassy Drug Microneedle Array Design: Drug Glass-Forming Ability and Stability.Mol Pharm. 2025 Mar 3;22(3):1373-1383. doi: 10.1021/acs.molpharmaceut.4c01067. Epub 2025 Feb 16. Mol Pharm. 2025. PMID: 39957277 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous